CN107254543A - PCR primer combination, kit and real time fluorescent quantitative detection method for detecting RhD mRNA spliceosomes - Google Patents

PCR primer combination, kit and real time fluorescent quantitative detection method for detecting RhD mRNA spliceosomes Download PDF

Info

Publication number
CN107254543A
CN107254543A CN201710674747.9A CN201710674747A CN107254543A CN 107254543 A CN107254543 A CN 107254543A CN 201710674747 A CN201710674747 A CN 201710674747A CN 107254543 A CN107254543 A CN 107254543A
Authority
CN
China
Prior art keywords
mrna
rhd
spliceosomes
pcr
primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710674747.9A
Other languages
Chinese (zh)
Other versions
CN107254543B (en
Inventor
梁延连
唐雄驰
张印则
吴凡
徐庆萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHEN BLOOD CENTER
Original Assignee
SHENZHEN BLOOD CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN BLOOD CENTER filed Critical SHENZHEN BLOOD CENTER
Priority to CN201710674747.9A priority Critical patent/CN107254543B/en
Publication of CN107254543A publication Critical patent/CN107254543A/en
Application granted granted Critical
Publication of CN107254543B publication Critical patent/CN107254543B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification

Abstract

It is used to detect the combination of RhD mRNA spliceosome real-time fluorescence quantitative PCRs primer, kit and detection method the invention discloses one kind, belongs to technical field of biological.The present invention is not disturbed by other non-target gene for the combination of RhD mRNA spliceosome sequences Design real-time fluorescence quantitative PCRs primer, the high specificity of the primer, quick, efficiently and accurately RhD mRNA spliceosomes can be quantified.Present invention application real time fluorescence quantifying PCR method is quantitatively detected that method is simple, accurate, is polluted in no pipeline, without gel electrophoresis, the method can be with the copy number of accurate quantitative analysis Different Individual RhD mRNA spliceosomes to RhD mRNA spliceosomes.As a result favorable reproducibility, detection sensitivity is high, high specificity, available for high-throughout sample detection.

Description

PCR primer combination, kit and real-time fluorescence for detecting RhD mRNA spliceosomes Quantitative detecting method
Technical field
The present invention relates to a kind of PCR primer combination for being used to detect RhD mRNA spliceosomes, also relate to draw comprising this The kit and RhD mRNA spliceosome real time fluorescent quantitative detection methods of thing combination, belong to technical field of biological.
Background technology
The complexity of RH genes is embodied directly in the polymorphism of RhD antigen presentations, this be considered as not only with RhD mRNA It is heterogeneous related about the missing also to related gene extron, quantity expression etc. in level.Le Van Kim etc. are gone back simultaneously It was found that:The gene transcript [1] that RHCE genes have alternative splicing and are variously formulated, same has researcher's hair There is the 7th extron to the alternative splicing [2] of the Various Complex of the 9th extron in the individual of normal D antigen positives now, The polymorphism of the spliceosome determines the characteristic of RHD gene expression D antigens.The genetic background of blood group gene has poor between obvious race It is different, it is because the RhD mRNA genes of different ethnic groups the various montage of selectivity occur and occurred caused by RhD hypotypes [3].MRNA is It, by DNA is via transcription, is that next step is translated into egg with corresponding hereditary message that messenger RNA mRNAs, which are, White matter provides required message.Based on RHD gene polynorphisms, the method for real time fluorescent quantitative is set up herein to Different Individual RhD mRNA spliceosomes are detected, the difference of Different Individual RHD genes is understood by monitoring the polymorphism of RhD mRNA expression.It is real When quantitative fluorescent PCR (real-time quantitative PCR)/QRT-PCR, refer to add in PCR reaction systems glimmering Signal thing, monitors whole PCR processes using the accumulation of fluorescence signal, unknown template is quantified by amplification curve in real time The method of analysis.
[1]LE VAN K C,MOURO I,CHERIF-ZAHAR B,et al.Molecular cloning and primary structure of the human blood group RhD polypeptideProe Natl.Acad Sei USA,1992,89(22):10925-10929.
[2] Shao Chaopeng, Xiong Wen, wait to substitute the RhD mRNA. China blood transfusion magazine that shearing forms diversified forms, 2004,17 (5):310-314.
[3] LE VAN K C, CHERIF-ZAHAR B, RAYNAL V, et al.Multiple Rh messenger RNA isoforms are produced by alternative splicing.Blood,1992,80(4):1074-1078.
The content of the invention
In order to overcome shortcoming and defect present in prior art, RhD is detected it is an object of the invention to provide one kind PCR primer combination, kit and the real-time fluorescence quantitative PCR detection method of mRNA spliceosomes.
The purpose of the present invention is achieved through the following technical solutions:
A kind of PCR primer combination for being used to detect RhD mRNA spliceosomes, includes at least one pair of of following three pairs of primers:
(1) it is used to expand 1 couples of total length RhD mRNA spliceosomes totally 2 primers, the sequence of 2 primers is respectively:
Sense primer:5'-CCCACAGCTCCATCATGGG-3'(SEQ ID NO:1),
Anti-sense primer:5'-GCCAATCATGCCATTGCCGGC-3'(SEQ ID NO:2);
(2) it is used for 1 couple totally 2 primers for expanding missing exon-7 RhD mRNA spliceosomes, the sequence difference of 2 primers For:
Sense primer:5'-TGGCTGGGCTGATCTCCG-3'(SEQ ID NO:3)
Anti-sense primer:5'-TGGAAGCCAATCCGGCAGGT-3'(SEQ ID NO:4);
(3) it is used to expanding missing exon-7,1 couples of 8,9 RhD mRNA spliceosomes totally 2 primers, the sequence of 2 primers Respectively:
Sense primer:5'-TGGCTGGGCTGATCTCCG-3'(SEQ ID NO:5)
Anti-sense primer:5'-CAAATGAGGAAACGGCAGGT-3'(SEQ ID NO:6).
Preferably, it is preferable that the concentration of each primer is 5pmol/L in the Primer composition.
A kind of kit of detection RhD mRNA spliceosomes, including described PCR primer combination thing.
Preferably, the described kit for being used to detect RhD mRNA spliceosomes also includes PCR grades of H2O, Master Mix。
A kind of real-time fluorescence quantitative PCR detection method for being used to detect RhD mRNA spliceosomes, comprises the following steps:
(3) several various concentrations standard items are prepared;
(4) PCR reaction solutions, including above-mentioned PCR primer combination thing are prepared;
(3) PCR is expanded:The standard items or testing sample of above-mentioned PCR reaction solutions and various concentrations are mixed into performing PCR respectively Amplification;
(4) the data creating standard curve obtained using the standard items of various concentrations;
(5) concentration of testing sample is calculated using standard curve.
Preferably, in the step (1), the standard items are selected from following at least one shown nucleotide sequence:
Total length standard items:
5'-CCCACAGCTCCATCATGGGCTACAACTTCAGCTTGCTGGGTCTGCTTG GAGAGATCATCTACATTGTGCTGCTGGTGCTTGATACCGTCGGAGCCGGCAA TGGCATGATTGGC-3'(SEQ ID NO:7)
Lack exon-7 standard items:
5'-TGGCTGGGCTGATCTCCGTCGGGGGAGCCAAGTACCTGCCGGATTGG CTTCCA-3'(SEQ ID NO:8)
Lack exon-7,8,9 standard items:
5'-TGGCTGGGCTGATCTCCGTCGGGGGAGCCAAGTACCTGCCGTTTCCTC ATTTG-3'(SEQ ID NO:9)。
Preferably, in the step (1), described some one kind in 6,8,10,12,16.
Preferably, the gradient between the step (1), the adjacent concentration of standard items of the various concentrations is 1 order of magnitude, I.e. concentration differs 10 times.
It is preferred that, in the step (2), PCR grades of H2O, Master Mix are also included in the PCR reaction solutions.
It is preferred that, in the step (3), the response procedures of PCR amplifications are:95 DEG C of pre-degeneration 10min;96 DEG C of denaturation 10s, 60 DEG C of renaturation 3s, 72 DEG C extend 3 seconds, circulate 35 times, 72 DEG C re-extend 10s.
Preferably, in the step (5), the calculating is carried out using 2nd Derivative Max calculating methods.
Main advantages of the present invention include:
The present invention for RhD mRNA spliceosome sequences Design real-time fluorescence quantitative PCRs primer combination, the primer it is special Property it is strong, do not disturbed, quick, efficiently and accurately RhD mRNA spliceosomes can be quantified by other non-target gene.
Present invention application real time fluorescence quantifying PCR method is quantitatively detected that method is simple, essence to RhD mRNA spliceosomes Really, polluted in no pipeline, without gel electrophoresis, the method can be with the copy of accurate quantitative analysis Different Individual RhD mRNA spliceosomes Number.As a result favorable reproducibility, detection sensitivity is high, high specificity, available for high-throughout sample detection.
Brief description of the drawings
Fig. 1 shows that whole blood extracts high-quality, high-purity mRNA electrophoretograms.
Fig. 2 RhD mRNA spliceosome real time fluorescent quantitatives are monitored in real time.
Embodiment
Following embodiments and test example are only described in further detail to the present invention, but do not constitute any limit to the present invention System.
Embodiment 1
The preparation method of the PCR primer combination thing of RhD mRNA spliceosomes is detected, Primer composition is drawn comprising following 3 Duis At least one pair of in thing:
For expanding 1 couples of total length RhD mRNA spliceosomes totally 2 primers, the sequence of 2 primers is respectively:
Sense primer:5'-CCCACAGCTCCATCATGGG-3'(SEQ ID NO:1),
Anti-sense primer:5'-GCCAATCATGCCATTGCCGGC-3'(SEQ ID NO:2);
For 1 couple totally 2 primers for the RhD mRNA spliceosomes for expanding missing exon-7, the sequence of 2 primers is respectively:
Sense primer:5'-TGGCTGGGCTGATCTCCG-3'(SEQ ID NO:3)
Anti-sense primer:5'-TGGAAGCCAATCCGGCAGGT-3'(SEQ ID NO:4);And
For expanding missing exon-7,1 couples of 8,9 RhD mRNA spliceosomes totally 2 primers, the sequence point of 2 primers It is not:
Sense primer:5'-TGGCTGGGCTGATCTCCG-3'(SEQ ID NO:5)
Anti-sense primer:5'-CAAATGAGGAAACGGCAGGT-3'(SEQ ID NO:6).
After upstream and downstream primer in equal volume mixing, that is, obtain Primer composition.
Preferably, the concentration of each primer is 5pmol/L in the Primer composition.
Embodiment 2
1 materials and methods
1.1 doses and instrument
MRNA extracts kits:LEV simplyRNA Blood Kit (are given birth to by Promega companies Production);CDNA reverse transcription reagent box:Transcriptor High Fidelity cDNA Synthesis Kit are (public by Roche Department's production);Real-time fluorescence quantitative PCR amplification instrument:Software is carried by German Roche Diagnostics GmbH For.RhD mRNA spliceosome pcr amplification primer things are synthesized by TaKaRa companies.
The preparation of 1.2 standard curves
1.2.1 artificial synthesized ssDNA as standard curve each spliceosome standard items of standard items, RhD mRNA and primer sequence Row are shown in Table 1.
1.2.2 standard items gradient dilution:Standard items are dissolved with distilled water, it is 50ng/ul to make its concentration.It is diluted to 10 The concentration of copy number, successively decrease 1 order of magnitude every time, totally 12 gradients:12 0.5ml PCR pipes are taken, since the 2nd pipe (the One pipe is stoste pipe) often pipe add distilled water 90ul, the .. that carries out mark 1,2,3 ..., 12, add 10ul in the 2nd dilution tube 50ng/ul ssDNA libraries, outstanding whirlpool suctions out 10ul and is added to the 3rd pipe, operates successively after mixing, until being diluted to last Pipe.The gradient dilution liquid of last pipe removes.
1.3PCR amplification operations:
1.3.1 mRNA is extracted, reverse transcription is cDNA, and using cDNA as detection sample.
1.3.2 standard items:Using respective standard items (table 1), and 3 multiple holes are set.
1.3.3 primer:The primer is that the upstream anti-sense primer described in embodiment 1 in three pairs of primers is mixed to get respectively Three kinds of Primer compositions.
1.3.4qPCR the operation of the system of sample-adding:It is shown in Table 2.
1.3.5 system amplification condition is shown in Table 3.
The standard items and sequence of each spliceosome cDNA real time fluorescent quantitatives detections of the RhD mRNA of table 1
Each spliceosome cDNA of the RhD mRNA of table 2 PCR sample-adding systems
Agent formulations Volume (μ L)
PCR grades of H2O 8.5
Primer composition (5pmol/L) 0.5
Master Mix 10
Standard items (or cDNA) 1
React cumulative volume 20
The RhD mRNA spliceosomes cDNA of table 3 shares PCR amplification conditions
The first step Second step (35 circulation) 3rd step
95℃ 10min 96℃ 10s 72℃ 10s
65℃ 3s 4℃ ∝
68℃ 3s
Each standard items or sample cDNA detect 3 multiple holes, finally take each hole reading and take the mean as detection Result.
1.3.6 each spliceosome amplification efficiencies of RhD mRNA
The amplification efficiency of full length sequence:1.978, the range of linearity:104~109
Lack the amplification efficiency of the sequences of exon 7:1.951, the range of linearity:103~108
Lack the amplification efficiency of the sequences of exon 7/8/9:1.878, the range of linearity:104~109
1.3.7 RhD mRNA cDNA quantitative calculation methods:2nd Derivative Max calculating methods.
2 results
2.1 RhD mRNA, which are extracted, need to reach standard:A260/A280 ratio range:Between 1.8~2.1.MRNA concentration> 0.8 μ g/ μ l, extract mRNA electrophoresis as shown in Figure 1 from whole blood.
2.2 monitor the real-time fluorescent signals in each PCR amplification cycles in real time, and real-time fluorescent signals represent amplified production Copy number, the accumulation of copy number is directly proportional to RhD mRNA spliceosome contents, and standard curve is as shown in Fig. 2.
Using standard curve, calculating obtains standard items and the quantitative result of testing sample is as shown in table 4.
Table 4 is quantified using standard curve to sample
The experimental result requirement of standard items reaches:Error<0.02;
Efficiency:Between 1.9~2.1;
The range of linearity:103~109Between.
The experimental result of standard items is in above controlled range, and the data of actual measurement sample are valid data.
All documents referred in the present invention are all incorporated as reference in this application, independent just as each document It is incorporated as with reference to such.In addition, it is to be understood that after the above-mentioned instruction content of the present invention has been read, those skilled in the art can To be made various changes or modifications to the present invention, these equivalent form of values equally fall within the model that the application appended claims are limited Enclose.
SEQUENCE LISTING
<110>Shenzhen Blood Center
<120>PCR primer combination, kit and real time fluorescent quantitative detection method for detecting RhD mRNA spliceosomes
<130> KH17-1-436
<160> 9
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> Whole-F
<400> 1
cccacagctc catcatggg 19
<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> Whole-R
<400> 2
gccaatcatg ccattgccgg c 21
<210> 3
<211> 18
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7-F
<400> 3
tggctgggct gatctccg 18
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7-R
<400> 4
tggaagccaa tccggcaggt 20
<210> 5
<211> 18
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7,8,9-F
<400> 5
tggctgggct gatctccg 18
<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7,8,9-R
<400> 6
caaatgagga aacggcaggt 20
<210> 7
<211> 113
<212> DNA
<213> Artificial Sequence
<220>
<223> Whole
<400> 7
cccacagctc catcatgggc tacaacttca gcttgctggg tctgcttgga gagatcatct 60
acattgtgct gctggtgctt gataccgtcg gagccggcaa tggcatgatt ggc 113
<210> 8
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7
<400> 8
tggctgggct gatctccgtc gggggagcca agtacctgcc ggattggctt cca 53
<210> 9
<211> 53
<212> DNA
<213> Artificial Sequence
<220>
<223> exon-7,8,9
<400> 9
tggctgggct gatctccgtc gggggagcca agtacctgcc gtttcctcat ttg 53

Claims (10)

1. a kind of PCR Primer compositions for being used to detect RhD mRNA spliceosomes, it is characterised in that including following three pairs of primers At least one pair of:
(1)For expanding 1 couples of total length RhD mRNA spliceosomes totally 2 primers, the sequence of 2 primers is respectively such as SEQ ID NO:1 and SEQ ID NO:Shown in 1,
(2)For 1 couple totally 2 primers for the RhD mRNA spliceosomes for expanding missing exon-7, the sequences of 2 primers is respectively such as SEQ ID NO:3 and SEQ ID NO:Shown in 4;;
(3)For expanding missing exon-7,1 couples of 8,9 RhD mRNA spliceosomes totally 2 primers, the sequence point of 2 primers Not such as SEQ ID NO:5 and SEQ ID NO:Shown in 6.
2. the PCR Primer compositions according to claim 1 for being used to detect RhD mRNA spliceosomes, it is characterised in that institute State primer concentration respectively 5pmol/L.
3. a kind of kit for being used to detect RhD mRNA spliceosomes, it is characterised in that combined including described PCR primers Thing.
4. the kit according to claim 3 for being used to detect RhD mRNA spliceosomes, it is characterised in that also including PCR Level H2O, Master Mix.
5. a kind of real-time fluorescence quantitative PCR detection method for being used to detect RhD mRNA spliceosomes, it is characterised in that including such as Lower step:
Prepare several various concentrations standard items;
Prepare PCR reaction solutions, including above-mentioned PCR primer combination thing;
(3)PCR is expanded:The standard items or testing sample of above-mentioned PCR reaction solutions and various concentrations are mixed into performing PCR respectively to expand Increase;
(4)The data creating standard curve obtained using the standard items of various concentrations;
(5)The concentration of testing sample is calculated using standard curve.
6. the real-time fluorescence quantitative PCR detection method according to claim 5 for being used to detect RhD mRNA spliceosomes, it is special Levy and be, the step(1)In, the standard items are selected from SEQ ID NO:At least one in nucleotide sequence shown in 7-9 Kind.
7. the real-time fluorescence quantitative PCR detection method according to claim 5 for being used to detect RhD mRNA spliceosomes, it is special Levy and be, the step(1)In, described some one kind in 6,8,10,12,16, it is preferable that the various concentrations Gradient between the adjacent concentration of standard items is that 1 order of magnitude, i.e. concentration differ 10 times.
8. the real-time fluorescence quantitative PCR detection method according to claim 5 for being used to detect RhD mRNA spliceosomes, it is special Levy and be, the step(2)In, PCR grades of H2O, Master Mix are also included in the PCR reaction solutions.
9. the real-time fluorescence quantitative PCR detection method according to claim 5 for being used to detect RhD mRNA spliceosomes, it is special Levy and be, the step(3)In, the response procedures of PCR amplifications are:95 DEG C of pre-degeneration 10min;96 DEG C of denaturation 10s, 60 DEG C multiple Property 3s, 72 DEG C extend 3 seconds, circulate 35 times, 72 DEG C re-extend 10s.
10. the real-time fluorescence quantitative PCR detection method according to claim 5 for being used to detect RhD mRNA spliceosomes, its It is characterised by, the step(5)In, the calculating is carried out using 2nd Derivative Max calculating methods.
CN201710674747.9A 2017-08-09 2017-08-09 PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome Active CN107254543B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710674747.9A CN107254543B (en) 2017-08-09 2017-08-09 PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710674747.9A CN107254543B (en) 2017-08-09 2017-08-09 PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome

Publications (2)

Publication Number Publication Date
CN107254543A true CN107254543A (en) 2017-10-17
CN107254543B CN107254543B (en) 2020-11-10

Family

ID=60026644

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710674747.9A Active CN107254543B (en) 2017-08-09 2017-08-09 PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome

Country Status (1)

Country Link
CN (1) CN107254543B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111304211A (en) * 2020-03-10 2020-06-19 无锡市第五人民医院 RHD-T268A mutant and detection thereof
CN114032320A (en) * 2021-10-21 2022-02-11 南京林业大学 Real-time fluorescence quantitative PCR detection method for plant alternative splicing and application
CN114317685A (en) * 2022-01-05 2022-04-12 苏州贝康医疗器械有限公司 Kit, library construction method and sequencing method for detecting mRNA variable shearing variation
CN116297120A (en) * 2023-03-30 2023-06-23 深圳市血液中心(深圳市输血医学研究所) Method for detecting drug antibody in sample

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1552918A (en) * 2003-12-15 2004-12-08 深圳市血液中心 Primer, reagent box and sizing method for Chinese the Han nationality crowd differential RHD gene sizing
US20110070590A1 (en) * 2009-09-22 2011-03-24 Jan Rohozinski Primers and Methods for Determining RhD Zygosity
CN102282176A (en) * 2008-07-18 2011-12-14 诺华有限公司 Non-invasive fetal rhd genotyping from maternal whole blood

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1552918A (en) * 2003-12-15 2004-12-08 深圳市血液中心 Primer, reagent box and sizing method for Chinese the Han nationality crowd differential RHD gene sizing
CN102282176A (en) * 2008-07-18 2011-12-14 诺华有限公司 Non-invasive fetal rhd genotyping from maternal whole blood
US20110070590A1 (en) * 2009-09-22 2011-03-24 Jan Rohozinski Primers and Methods for Determining RhD Zygosity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OGASAWARA K等: "Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression", 《VOX SANGUINIS》 *
张玉娴等: "RHD基因转录子的选择性剪切", 《华东师范大学学报(自然科学版)》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111304211A (en) * 2020-03-10 2020-06-19 无锡市第五人民医院 RHD-T268A mutant and detection thereof
CN111304211B (en) * 2020-03-10 2020-12-01 无锡市第五人民医院 RHD-T268A mutant and detection thereof
CN114032320A (en) * 2021-10-21 2022-02-11 南京林业大学 Real-time fluorescence quantitative PCR detection method for plant alternative splicing and application
CN114317685A (en) * 2022-01-05 2022-04-12 苏州贝康医疗器械有限公司 Kit, library construction method and sequencing method for detecting mRNA variable shearing variation
CN114317685B (en) * 2022-01-05 2023-10-20 苏州贝康医疗器械有限公司 Kit for detecting mRNA variable shear variation, library building method and sequencing method
CN116297120A (en) * 2023-03-30 2023-06-23 深圳市血液中心(深圳市输血医学研究所) Method for detecting drug antibody in sample
CN116297120B (en) * 2023-03-30 2023-12-01 深圳市血液中心(深圳市输血医学研究所) Method for detecting drug antibody in sample

Also Published As

Publication number Publication date
CN107254543B (en) 2020-11-10

Similar Documents

Publication Publication Date Title
Zhu et al. Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19
CN107254543A (en) PCR primer combination, kit and real time fluorescent quantitative detection method for detecting RhD mRNA spliceosomes
CN109811055A (en) Sarcoma fusion detection kit and system
Hall et al. Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA
CN105018646B (en) A kind of primer, probe and the kit of detection bovine epizootic fever virus
Buehler et al. Rapid quantification of DNA libraries for next-generation sequencing
WO2019144582A1 (en) Probe and method for high-throughput sequencing targeted capture target region used for detecting gene mutations as well as known and unknown gene fusion types
CN104651488B (en) Detect the Amplification thing and quick detection kit of chromosome aneuploid numerical abnormality
Pater et al. High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
WO2018184495A1 (en) Method for constructing amplicon library through one-step process
CN106701978A (en) Human microsatellite instability (MSI) detection amplification primer composition and kit
CN105861641A (en) Primer, kit and method for detecting CHO cell DNA residues
CN105039322B (en) DNA sequence labels and sequencing library construction method and kit
CN109837275B (en) Preparation method of fusion gene positive control standard substance
CN106191311B (en) A kind of multiple liquid phase genetic chip method and reagent of quick detection cavy LCMV, SV, PVM, Reo-3 virus
CN115786459B (en) Method for detecting tiny residual disease of solid tumor by high-throughput sequencing
Neumann et al. Padlock probe assay for detection and subtyping of seasonal influenza
WO2020047769A1 (en) Method for building rna library and kit
CN106148484B (en) A kind of kit that diagnosis Y chromosome is micro-deleted
WO2019001187A1 (en) Multi-liquid phase gene chip detection primer, kit and method for rapidly distinguishing five pathogens in mouse respiratory tracts
CN111793703B (en) Kit for detecting mycobacterium tuberculosis nucleic acid by enzyme digestion probe at constant temperature
CN109777861A (en) The loop-mediated isothermal amplification method of mispairing tolerance and application
CN110938708B (en) Kit for detecting H7N9 avian influenza virus based on isothermal amplification technology and application thereof
CN106521035B (en) Gene chip detection kit and method for detecting 16 respiratory pathogens
CN106011313B (en) A kind of the multi-fluorescence immunoassay method and reagent of quick differentiation ILTV, IBV, MG and MS

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant